This approach to modulate CDK6 expression without complete loss of CDK6 or suppression of CDK4 expression may have an ameliorative effect on RASF proliferation in the joints of patients with RA without causing excessive immunosuppression. This evidence concerns the gene CDK4 and rheumatoid arthritis.